36 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
and clinical development status: Figure 1: Pipeline Chart WW Worldwide EU European Union OUS Outside the U.S. Our Strategy Our goal is to transform …
Equivalent, and similarly detailed, obligations will apply to the conduct of clinical trials in third countries including the European Union (“EU
8-K
EX-1.1
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
Assets Control (“OFAC”), the United Nations Security Council, the European Union, His Majesty’s Treasury, or other relevant sanctions authority … , the FDA, the U.S. Department of Health and Human Services and applicable European Union data protection authorities, in each case of the foregoing
424B5
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Prospectus supplement for primary offering
5:17pm
/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
Canada
The securities may be sold in Canada only
424B5
TARS
Tarsus Pharmaceuticals Inc
29 Feb 24
Prospectus supplement for primary offering
5:08pm
Union (Withdrawal) Act 2018.
Canada
The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal
S-3ASR
EX-4.5
TARS
Tarsus Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
4:32pm
of one or more countries or by any recognized union, association or confederation of governments that issued such Foreign Currency and by a central … , composite currency or currency unit and Foreign Currency issued by the government of one or more countries or by any recognized union, confederation
8-K
EX-1.1
e9kq6d
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
424B5
n7dwwu
2 Aug 23
Prospectus supplement for primary offering
4:08pm
424B5
hzgkche5114d53tlnu8b
31 Jul 23
Prospectus supplement for primary offering
5:13pm
ARS
qug d7nlgf
26 Apr 23
Annual report to shareholders
4:08pm
8-K
EX-1.1
b0wod1443qjjcruc
3 May 22
Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock
8:34pm
424B5
nnfnjp1zujhtyu0gjnyq
3 May 22
Prospectus supplement for primary offering
8:29pm
424B5
wvrh 7xprd1mtk4xv
2 May 22
Prospectus supplement for primary offering
7:26am